CardioVascular Center

Cardiac Amyloidosis Program

The Cardiac Amyloidosis Program at Tufts Medical Center provides efficient and expert diagnosis and treatment for patients with suspected or established cardiac amyloidosis.

The resources of the CardioVascular Center provide state-of-the art imaging for the diagnosis of cardiac amyloidosis, including technetium pyrophosphate (PYP) scanning, cardiac MRI and echocardiography.

For patients with known cardiac amyloidosis, we provide expert care including amyloid-specific therapies and management of heart failure.

We work closely with patients’ local physicians to coordinate care and bring care to Boston only when necessary. In Boston, we collaborate with faculty from the John C. Davis Myeloma and Amyloid Program in the Tufts Medical Center Cancer Center for patients who have suspected or known light chain (AL) cardiac amyloidosis.

 

Amyloidosis is a condition in which an abnormal protein known as amyloid, deposits in organs of the body. There are different types of amyloid and the treatment approach depends on which type of amyloid an individual has.

Some types of amyloid can affect the heart, called cardiac amyloidosis, and can lead to problems such as heart failure and heart rhythm abnormalities.

 

Ayan R. Patel, MD

Ayan R. Patel, MD

Accepting New Patients

Title(s): Director, Cardiovascular Imaging and Hemodynamic Laboratory; Director, Women's Heart Center; Professor, Tufts University School of Medicine
Department(s): Medicine, CardioVascular Center, Cardiology
Appt. Phone: 617-636-2273
Fax #: 617-636-8070

Echocardiography, heart failure, women's heart disease, cardiac amyloidosis

View Full Profile for Ayan R. Patel, MD

Raymond Comenzo, MDRaymond Comenzo, MD

 

 

 

 

 

 

 

 

 

Cindy Varga, MD, an oncologist at Tufts Medical Center in Boston.Cindy Varga, MD